Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
ChengDu Sheng Nuo Biotec
688117
4
THEC
833509
5
Shenzhen Jasic Technology
300193
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -8.69%10.02B | -11.64%6.65B | -5.44%4.67B | -5.80%2.28B | -7.64%10.97B | 0.71%7.53B | 1.07%4.94B | 24.39%2.42B | 5.16%11.88B | -9.21%7.48B |
Operating revenue | -8.69%10.02B | -11.64%6.65B | -5.44%4.67B | -5.80%2.28B | -7.64%10.97B | 0.71%7.53B | 1.07%4.94B | 24.39%2.42B | 5.16%11.88B | -9.21%7.48B |
Other operating revenue | 53.11%258.85M | ---- | -33.26%80.76M | ---- | -14.24%169.06M | ---- | 2.35%121.02M | ---- | -16.63%197.14M | ---- |
Total operating cost | -10.01%9.06B | -12.14%6.07B | -6.84%4.26B | -7.24%2.08B | -6.73%10.07B | 1.55%6.91B | 1.63%4.57B | 26.93%2.24B | 4.59%10.8B | -8.83%6.8B |
Operating cost | -10.07%7.53B | -12.43%5.03B | -5.70%3.58B | -6.59%1.77B | -7.98%8.37B | 1.71%5.75B | 2.14%3.79B | 33.08%1.9B | 4.87%9.1B | -11.29%5.65B |
Operating tax surcharges | 8.40%84.94M | 9.68%56.73M | 10.23%36.77M | 7.52%15.94M | -1.09%78.36M | 8.87%51.72M | 2.29%33.35M | 23.57%14.82M | -3.59%79.23M | -4.84%47.51M |
Operating expense | -2.75%286.99M | -2.90%183.21M | -4.66%117.38M | 5.02%55.96M | 12.35%295.09M | 4.87%188.69M | 8.30%123.12M | 3.59%53.29M | -1.44%262.66M | -0.29%179.92M |
Administration expense | -11.85%609.65M | -19.38%368.08M | -25.58%247.8M | -7.34%118.08M | 6.18%691.59M | 3.46%456.56M | 4.44%332.97M | 8.66%127.43M | 6.28%651.36M | 8.04%441.28M |
Financial expense | -33.95%102.31M | -9.26%104.83M | -8.75%68.38M | -33.57%32.5M | -11.50%154.9M | 2.65%115.52M | -14.32%74.94M | -6.98%48.93M | -8.07%175.02M | -13.55%112.54M |
-Interest expense (Financial expense) | -28.61%142.39M | -18.50%128.66M | -22.69%84.3M | -20.39%43.58M | -12.64%199.46M | -7.23%157.87M | -4.96%109.04M | -1.40%54.74M | 17.73%228.32M | 27.55%170.16M |
-Interest Income (Financial expense) | -8.25%-46.01M | -2.63%-34.79M | -5.40%-21.4M | -53.81%-14.44M | -54.16%-42.51M | -35.27%-33.9M | -30.57%-20.3M | -27.69%-9.38M | -31.92%-27.57M | -88.73%-25.06M |
Research and development | -6.08%447.11M | -7.02%323.28M | -1.07%208.89M | -15.38%84.03M | -9.92%476.08M | -6.04%347.7M | -7.88%211.16M | -6.73%99.3M | 6.92%528.52M | 14.95%370.07M |
Credit Impairment Loss | -246.63%-25.28M | -50.11%46.14M | -70.26%25.94M | -148.90%-1.14M | 107.55%17.24M | 574.54%92.47M | 952.76%87.2M | -86.08%2.33M | -45.02%-228.39M | 42.78%-19.49M |
Asset Impairment Loss | 60.34%-165.72M | 88.61%-3.73M | -70.43%-16.05M | -184.17%-9.27M | -393.09%-417.89M | -105.40%-32.7M | 10.17%-9.42M | 65.69%-3.26M | -165.88%-84.75M | 58.73%-15.92M |
Other net revenue | 111.71%25.14M | 18.36%188.27M | -23.01%109.92M | 24.92%39.02M | -51.31%-214.6M | 147.81%159.07M | 186.79%142.77M | -2.17%31.23M | -2,080.79%-141.83M | 67.78%64.19M |
Fair value change income | ---- | ---- | ---- | ---- | -200.00%-2.44M | ---2.44M | ---202.99K | ---1.67M | --2.44M | ---- |
Invest income | -15.51%54.74M | 11.62%45.41M | 23.34%31.78M | 19.62%15.25M | 6.56%64.79M | 25.65%40.68M | 15.75%25.77M | 23.40%12.75M | 26.49%60.8M | 6.68%32.37M |
-Including: Investment income associates | -8.04%6.37M | 27.93%6.2M | 313.81%6M | 1,170.25%1.73M | -34.92%6.93M | -42.89%4.85M | -74.03%1.45M | -107.19%-161.46K | 2,907.29%10.65M | 498.68%8.49M |
Asset deal income | 50.71%12.29M | 248.53%4.66M | 92.20%1.2M | -175.93%-307.14K | 221.11%8.16M | 59.17%1.34M | -9.74%623.74K | -39.22%404.48K | -89.70%2.54M | -96.69%839.94K |
Other revenue | 29.05%149.1M | 60.39%95.8M | 72.80%67.05M | 66.73%34.49M | 9.49%115.54M | -10.03%59.73M | -18.38%38.8M | 51.23%20.68M | -14.76%105.52M | 20.35%66.38M |
Operating profit | 42.94%982.61M | -1.17%772.59M | 2.10%526.61M | 14.04%239.73M | -26.93%687.44M | 5.76%781.76M | 16.19%515.79M | -0.76%210.21M | -3.98%940.79M | -9.16%739.2M |
Add:Non operating Income | -17.54%9.5M | -0.02%6.36M | -24.72%2.99M | 142.67%2M | 72.80%11.52M | 51.75%6.36M | 159.27%3.97M | 4.13%826.03K | -41.20%6.67M | -47.78%4.19M |
Less:Non operating expense | -65.42%16.31M | -46.83%14.15M | 297.53%11.92M | 165.29%6.32M | 401.38%47.18M | 330.39%26.61M | -32.50%3M | 71.10%2.38M | -34.63%9.41M | -14.07%6.18M |
Total profit | 49.71%975.8M | 0.43%764.81M | 0.18%517.67M | 12.83%235.42M | -30.52%651.79M | 3.30%761.51M | 17.18%516.75M | -1.22%208.65M | -3.96%938.05M | -9.50%737.21M |
Less:Income tax cost | 4.54%153.01M | -4.28%115.84M | -5.11%85.56M | 44.24%38.51M | 13.61%146.36M | 21.42%121.02M | 58.20%90.16M | -21.23%26.7M | 22.16%128.82M | -12.66%99.67M |
Net profit | 62.79%822.79M | 1.32%648.97M | 1.30%432.12M | 8.22%196.9M | -37.54%505.43M | 0.46%640.49M | 11.09%426.59M | 2.61%181.95M | -7.12%809.23M | -8.99%637.54M |
Net profit from continuing operation | 65.86%822.79M | 1.32%648.97M | 1.30%432.12M | 8.22%196.9M | -39.80%496.07M | 0.46%640.49M | 11.09%426.59M | 2.61%181.95M | -5.42%824.02M | -8.99%637.54M |
Net income from discontinuing operating | ---- | ---- | ---- | ---- | 163.30%9.36M | ---- | ---- | ---- | ---14.79M | ---- |
Less:Minority Profit | -115.04%-7.61M | 238.36%1.53M | 157.54%765.11K | 30.73%-2.04M | -176.97%-3.54M | -175.78%-1.1M | -159.40%-1.33M | -524.61%-2.95M | -57.79%4.6M | -80.24%1.46M |
Net profit of parent company owners | 63.15%830.4M | 0.91%647.45M | 0.80%431.35M | 7.60%198.95M | -36.74%508.97M | 0.87%641.59M | 12.09%427.92M | 4.00%184.9M | -6.48%804.63M | -8.23%636.08M |
Earning per share | ||||||||||
Basic earning per share | 63.83%0.77 | 0.00%0.6 | 0.00%0.4 | 5.88%0.18 | -37.33%0.47 | 1.69%0.6 | 11.11%0.4 | 0.00%0.17 | -6.25%0.75 | -9.23%0.59 |
Diluted earning per share | 71.11%0.77 | 1.85%0.55 | 0.00%0.36 | 6.25%0.17 | -33.82%0.45 | 0.00%0.54 | 9.09%0.36 | 6.67%0.16 | -6.85%0.68 | -8.47%0.54 |
Other composite income | 339.39%1.3M | -215.14%-870.11K | 14,557.65%3.34M | 352.94%2.64M | 68.63%-544.09K | -66.66%755.69K | -162.27%-23.1K | -422.18%-1.04M | -45.97%-1.73M | 356.23%2.27M |
Other composite income of parent company owners | 339.39%1.3M | -215.14%-870.11K | 14,557.65%3.34M | 352.94%2.64M | 68.63%-544.09K | -66.66%755.69K | -162.27%-23.1K | -422.18%-1.04M | -45.97%-1.73M | 356.23%2.27M |
Total composite income | 63.22%824.09M | 1.07%648.1M | 2.08%435.46M | 10.30%199.54M | -37.47%504.89M | 0.23%641.25M | 11.08%426.57M | 1.83%180.91M | -7.19%807.5M | -8.55%639.8M |
Total composite income of parent company owners | 63.58%831.71M | 0.66%646.58M | 1.59%434.69M | 9.64%201.59M | -36.68%508.43M | 0.63%642.35M | 12.08%427.9M | 3.22%183.86M | -6.55%802.9M | -7.78%638.35M |
Total composite income of minority owners | -115.04%-7.61M | 238.36%1.53M | 157.54%765.11K | 30.73%-2.04M | -176.97%-3.54M | -175.78%-1.1M | -159.40%-1.33M | -524.61%-2.95M | -57.79%4.6M | -80.24%1.46M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.